Delivery Order SPE2DB22D2206-SPE2DB23FJF45
Award Date
7/17/23
Potential Completion Date
8/7/23
Potential Value
$8.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $4,229.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ZOLADEX 10.8 mg implants. As the prime contractor, Amerisourcebergen will provide the implants to support the Defense Logistics Agency's medical supply needs. Performance will take place in Conshohocken, Pennsylvania over a three week period concluding on August 23, 2023. The delivery order was issued against an existing Amerisourcebergen contract vehicle but no additional...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,754.58 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, with a completion date of March 15, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA, which has a potential value of $999,999,999.00 and a performance period...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a pharmaceutical product. The contract has a potential value of $3,509.16 and a completion date of January 31, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract awards from DLA to provide...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,191,600 units of ZOLADEX 10.8 MG IMPLANT SYRNS. The $16,919.60 award has a completion date of January 18, 2024 and was made on December 26, 2023. Amerisourcebergen Drug Corp, as a prime contractor, has a history of supplying pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support Medical...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $5,263.74 firm fixed price contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has a completion date of March 4, 2024 and was awarded on February 9, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide...
This federal contract award, valued at $20,303.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialized medical product, with a completion date of September 18, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,509.16 to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, with a completion date of June 13, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,610,200 units of the pharmaceutical product ZOLADEX 10.8 MG IMPLANT SYRNS. The contract has a completion date of February 29, 2024 and a potential value of $8,772.80. No set-aside designation was used for this award. AmerisourceBergen Drug Corp serves as a prime contractor to DLA, providing a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS. The contract has a ceiling value of $10,527.36 and a performance period through April 18, 2024. This delivery order is placed under an existing indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a...
The Defense Logistics Agency awarded a $1,692 delivery order to Amerisourcebergen Drug Corporation for Zoladex 10.8 mg implants. As the prime contractor, Amerisourcebergen will supply the pharmaceutical product to the Defense Logistics Agency from its facility in Conshohocken, Pennsylvania under a firm fixed price contract running from September 27 to October 19, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside...